Duker Jay S. Insider Trades

Insider Trading History

Track insider trading activity for Duker Jay S.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $2.18M 177,431 shares
Last Trade
Mar 23, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.91M 226,766 shares
$12.83
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $1.01M 82,500 shares
Last Trade
Mar 23, 2026 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$2.91M 226,766 shares
$12.83
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $1.23M 100,665 shares
Last Trade
Mar 16, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.7k 1,500 shares
$13.15
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $0 0 shares
Last Trade
Jan 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$351k 20,793 shares
$16.86
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $1.08M 87,806 shares
Last Trade
Jan 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$351k 20,793 shares
$16.86
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $953k 77,752 shares
Last Trade
Jan 06, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$170k 10,054 shares
$16.86
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $822k 67,013 shares
Last Trade
Jan 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$253k 14,505 shares
$17.43
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $368k 30,000 shares
Last Trade
Jan 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$523k 30,000 shares
$17.43
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $999k 81,518 shares
Last Trade
Jan 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$523k 30,000 shares
$17.43
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $1.59M 130,000 shares
Last Trade
Jan 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.14M 65,000 shares
$17.48
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $632k 51,518 shares
Last Trade
Jan 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$410k 23,447 shares
$17.48
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $919k 74,965 shares
Last Trade
Jan 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.14M 65,000 shares
$17.48
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $4.06M 331,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.67M 496,000 shares
$17.48
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $204k 16,667 shares
Last Trade
Jul 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$184k 16,667 shares
$11.06
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $122k 9,965 shares
Last Trade
Jul 10, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$85k 7,688 shares
$11.06
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $216k 17,653 shares
Last Trade
Jul 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$184k 16,667 shares
$11.06
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $12.1k 986 shares
Last Trade
Jun 23, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$465k 56,665 shares
$8.21
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $707k 57,651 shares
Last Trade
Mar 19, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$123k 20,000 shares
$6.16
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $952k 77,651 shares
Last Trade
Feb 09, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.4k 2,055 shares
$6.50
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
President And CEO
Holding Value $0 0 shares
Last Trade
Feb 09, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$45.5k 7,000 shares
$6.50
$12.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up